featured
Future of Incretins in Treatment of Obesity and NAFLD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetologia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease
Diabetologia 2023 Oct 01;66(10)1846-1858, CR Andreasen, A Andersen, T VilsbøllFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.